Experience and result of extracorporeal membrane oxygenation in treating fulminant myocarditis with shock: What mechanical support should be considered first?

Journal of Heart and Lung Transplantation

Volumn 24, Issue 1, 2005, Pages 81-87

  Chen, Yih Sharng ^a   Yu, Hsi Yu ^a   Huang, Shu Chien ^a   Chiu, Kaung Ming ^b   Lin, Tzu Yu ^b   Lai, Lin Ping ^a   Lin, Fang Yue ^a   Wang, Shoei Shan ^a   Chu, Shu Hsun ^b   Ko, Wen Je ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CATECHOLAMINE; DOBUTAMINE; DOPAMINE; HEART ENZYME; INOTROPIC AGENT; LIVER ENZYME; MILRINONE; NORADRENALIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AORTA BALLOON; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME BLOOD LEVEL; EXTRACORPOREAL OXYGENATION; FOLLOW UP; HEART GRAFT; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MASSAGE; HEMOFILTRATION; HEMOSTASIS; HUMAN; HYPOTENSION; MYOCARDITIS; NEUROLOGICAL COMPLICATION; OLIGURIA; PACEMAKER; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; SHOCK; VENTILATOR;

EID: 19944426540     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2003.09.038     Document Type: Article

References (24)

1. Maze S.S., Adolph R.J. Myocarditis unresolved issues in diagnosis and treatment. Clin Cardiol. 13:1990;69-79
2. Grogan M., Redfiled M.M., Bailey K.R., et al. Long-term outcome of patients with biopsy-proven myocarditis comparison with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 26:1995;80-84
3. Dec G.W., Palacios I.F., Fallon J.T., et al. Acute myocarditis in the spectrum of acute dilated cardiomyopathies. N Engl J Med. 312:1985;885-890
4. Hosenpud J.D., McAnulty J.H., Niles N.R. Lack of objective improvement in ventricular systolic function in patients with myocarditis treated with azithioprine and prednisone. J Am Coll Cardiol. 6:1985;797-801
5. Chen J.M., Spanier T.B., Gonzalez J.J., et al. Improved survival inpatients with acute myocarditis using external pulsatile mechanical ventricular assistance. J Heart Lung Transplant. 18:1999;351-357
6. Houel R., Vermes E., Tixier D.B., et al. Myocardial recovery after mechanical support for acute myocarditis is sustained recovery predictable? Ann Thorac Surg. 68:1999;2177-2180
7. Uedo T., Bergin P., Richardson M., et al. Bridge to recovery with left ventricular assist device for fulminant acute myocarditis. Ann Thorac Surg. 69:2000;284-286
8. Rockman H.A., Adamson R.M., Dembitsky W.P., et al. Acute fulminant myocarditis long-term follow-up after circulatory support with left ventricular assist device. Am Heart J. 121:1991;922-926
9. Marelli D., Laks H., Amsel B., et al. Temporary mechanical support with the BVS 5000 assist device during treatment of acute myocarditis. J Card Surg. 12:1997;55-59
10. Lieberman E.B., Hutchins G.M., Herskowitz A., Rose N.R., Baughman K.L. Clinicopathologic description of myocarditis. J Am Coll Cardiol. 18:1991;1617-1626
11. Chen Y.S., Ko W.J., Lin F.Y., et al. Preliminary result of an algorithm to select proper ventricular assist device for high-risk patients with extracorporeal membrane oxygenation support. J Heart Lung Transplant. 20:2001;850-857
12. Chen Y.S., Wang M.J., Chou N.K., et al. Rescue for acute myocarditis with shock by extracorporeal membrane oxygenation. Ann Thorac Surg. 68:1999;2220-2224
13. Greason K.L., Hemp J.R., Maxwell J.M., Fetter J.E., Moreno-Cabral R.J. Prevention of distal limb ischemia during cardiopulmonary support via femoral cannulation. Ann Thorac Surg. 60:1995;209-210
14. Aretz H.T., Billingham M.E., Edward W.D., et al. Myocarditis a histopathologic definition and classification. Am J Cardiovasc Pathol. 1:1987;3-14
15. McNamara D.M., Rosenblum W.D., Janosko K.M., et al. Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy. Circulation. 95:1997;2476-2478
16. Chang L.Y., Lin T.Y., Hsu K.H., et al. Clinical features and risk factors of pulmonary edema after enterovirus-71-related hand, foot, and mouth disease. Lancet. 354:1999;1682-1686
17. Huang C.C., Liu C.C., Chang Y.C., et al. Neurologic complications in children with enterovirus 71 infection. N Engl J Med. 341:1999;936-942
18. Wang S.M., Liu C.C., Tseng H.W., et al. Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin Infect Dis. 29:1999;184-190
19. Greenwood R.D., Nadas A.S., Fyler D.C. The clinical course of primary myocardial disease in infants and children. Am Heart J. 92:1973;549-560
20. Fenoglio J.J.J., Ursell P.C., Kellogg C.F., et al. Diagnosis and classification of myocarditis by endomyocardial biopsy. N Engl J Med. 308:1983;12-18
21. Kawai C., Matsumori A., Fujiwara H. Myocarditis and dilated cardiomyopathy. Ann Rev Med. 38:1987;221-239
22. McCarthy R.E., Boehmer J.P., Hruban R.H., et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med. 342:2000;690-695
23. Martin J., Sarai K., Schindle R.M., et al. MEDOS HIA-VAD biventricular assist device for bridge to recovery in fulminant myocarditis. Ann Thorac Surg. 63:1997;1145-1146
24. Cooper L.T., Berry G.J., Shabetai R. Idiopathic giant-cell myocarditis - natural history and treatment. N Engl J Med. 336:1997;1860-1866